Danaher (NYSE:DHR) Earns "Neutral" Rating from Rothschild & Co Redburn

Key Points

• Rothschild & Co Redburn has reissued a "neutral" rating on Danaher's stock, lowering the price objective from $245.00 to $220.00.
• Danaher reported a quarterly earnings per share (EPS) of $1.80, exceeding analysts' expectations of $1.64, and expects an EPS of 7.63 for the current fiscal year.
• Seventeen research analysts have given Danaher a “Buy” rating, while five have rated it as a “Hold,” with an average price target of $244.60.

Danaher (NYSE:DHR - Get Free Report)'s stock had its "neutral" rating reissued by equities research analysts at Rothschild & Co Redburn in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $220.00 price objective on the conglomerate's stock, down from their previous price objective of $245.00. Rothschild & Co Redburn's target price would suggest a potential upside of 5.45% from the company's current price.

Several other research firms have also commented on DHR. Guggenheim reiterated a "buy" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a report on Tuesday, September 2nd. Wells Fargo & Company lowered their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. Finally, Redburn Partners set a $220.00 price target on shares of Danaher in a report on Wednesday. Seventeen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $244.60.

Danaher Stock Performance

Shares of NYSE DHR opened at $208.63 on Wednesday. Danaher has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a market cap of $149.39 billion, a P/E ratio of 44.39, a P/E/G ratio of 3.02 and a beta of 0.77. The firm's fifty day moving average is $200.40 and its two-hundred day moving average is $197.32. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same period last year, the company posted $1.72 EPS. The business's revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts anticipate that Danaher will post 7.63 EPS for the current fiscal year.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the firm's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 11.20% of the company's stock.

Institutional Investors Weigh In On Danaher

Hedge funds and other institutional investors have recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $1,979,503,000. Nuveen LLC acquired a new position in shares of Danaher in the first quarter valued at approximately $833,941,000. Viking Global Investors LP grew its holdings in shares of Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate's stock valued at $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. Generation Investment Management LLP grew its holdings in shares of Danaher by 56.2% in the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate's stock valued at $980,914,000 after purchasing an additional 1,787,522 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Danaher by 44.5% in the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock valued at $965,259,000 after purchasing an additional 1,450,703 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.